Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name KTE-C19
Trade Name Yescarta
Synonyms KTE-C19 CAR|axicabtagene ciloleucel
Drug Descriptions

Yescarta (KTE-C19) is an immunotherapy consisted of peripheral T-lymphocytes engineered to express a chimeric antigen receptor targeting CD19, CD28 and CD3zeta, resulting in immunostimulating and antineoplastic activities (Blood 2015 126:3991). Yescarta (KTE-C19) is FDA approved for treatment of relapsed or refractory large B-cell lymphoma (FDA.gov).

CAS Registry Number NA
NCIT ID C120309


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Acalabrutinib + KTE-C19 Acalabrutinib KTE-C19 0 1
Anakinra + Cyclophosphamide + Fludarabine + KTE-C19 Anakinra Cyclophosphamide Fludarabine KTE-C19 0 1
Atezolizumab + KTE-C19 Atezolizumab KTE-C19 0 1
Cyclophosphamide + Fludarabine + KTE-C19 Cyclophosphamide Fludarabine KTE-C19 0 4
Cyclophosphamide + Fludarabine + KTE-C19 + Lenalidomide Cyclophosphamide Fludarabine KTE-C19 Lenalidomide 0 1
Cyclophosphamide + Fludarabine + KTE-C19 + Rituximab Cyclophosphamide Fludarabine KTE-C19 Rituximab 0 1
KTE-C19 KTE-C19 2 7
KTE-C19 + Lenzilumab KTE-C19 Lenzilumab 0 1
KTE-C19 + Utomilumab KTE-C19 Utomilumab 0 1

Additional content available in CKB BOOST